The Journal of Clinical Pharmacology

Cover image for The Journal of Clinical Pharmacology

December 1999

Volume 39, Issue 12

Pages 1203–1296

  1. Special Review

    1. Top of page
    2. Special Review
    3. Drug Metabolism
    4. Psychopharmacology
    5. Methods
    6. Pediatrics
    7. Pharmacokinetics and Pharmacodynamics
    8. Drug Interactions
    9. Adverse Effects
    10. Author Index, Volume 39 (1999)
  2. Drug Metabolism

    1. Top of page
    2. Special Review
    3. Drug Metabolism
    4. Psychopharmacology
    5. Methods
    6. Pediatrics
    7. Pharmacokinetics and Pharmacodynamics
    8. Drug Interactions
    9. Adverse Effects
    10. Author Index, Volume 39 (1999)
    1. Concurrent Administration of the Erythromycin Breath Test (EBT) and Oral Midazolam as In Vivo Probes for CYP3A Activity (pages 1212–1220)

      Dr. Jacqueline McCrea, Dr. Thomayant Prueksaritanont, Dr. Barry J. Gertz, Dr. Alexandra Carides, Ms. Lisa Gillen, Ms. Suzanne Antonello, Ms. Mary Jo Brucker, Ms. Cynthia Miller-Stein, Ms. Barbara Osborne and Dr. S. Waldman

      Version of Record online: 8 MAR 2013 | DOI: 10.1177/00912709922012015

  3. Psychopharmacology

    1. Top of page
    2. Special Review
    3. Drug Metabolism
    4. Psychopharmacology
    5. Methods
    6. Pediatrics
    7. Pharmacokinetics and Pharmacodynamics
    8. Drug Interactions
    9. Adverse Effects
    10. Author Index, Volume 39 (1999)
    1. The Frequency of Caffeine Withdrawal in a Population-Based Survey and in a Controlled, Blinded Pilot Experiment (pages 1221–1232)

      Dr. Peter B. Dews, Dr. Gary L. Curtis, Dr. Kathryn J. Hanford and Dr. Charles P. O'Brien

      Version of Record online: 8 MAR 2013 | DOI: 10.1177/00912709922012024

  4. Methods

    1. Top of page
    2. Special Review
    3. Drug Metabolism
    4. Psychopharmacology
    5. Methods
    6. Pediatrics
    7. Pharmacokinetics and Pharmacodynamics
    8. Drug Interactions
    9. Adverse Effects
    10. Author Index, Volume 39 (1999)
  5. Pediatrics

    1. Top of page
    2. Special Review
    3. Drug Metabolism
    4. Psychopharmacology
    5. Methods
    6. Pediatrics
    7. Pharmacokinetics and Pharmacodynamics
    8. Drug Interactions
    9. Adverse Effects
    10. Author Index, Volume 39 (1999)
    1. The Pharmacokinetics of Oral Ranitidine in Children and Adolescents with Cystic Fibrosis (pages 1242–1247)

      Dr. Laura P. James, Dr. Cindy D. Stowe, Dr. Henry C. Farrar, Dr. Astryd A. Menendez and Dr. Eric A. Argao

      Version of Record online: 8 MAR 2013 | DOI: 10.1177/00912709922012042

  6. Pharmacokinetics and Pharmacodynamics

    1. Top of page
    2. Special Review
    3. Drug Metabolism
    4. Psychopharmacology
    5. Methods
    6. Pediatrics
    7. Pharmacokinetics and Pharmacodynamics
    8. Drug Interactions
    9. Adverse Effects
    10. Author Index, Volume 39 (1999)
    1. Clinical Pharmacokinetics of the CD19 Receptor-Directed Tyrosine Kinase Inhibitor B43-Genistein in Patients with B-Lineage Lymphoid Malignancies (pages 1248–1255)

      Chun-Lin Chen, Alexandra Levine, Asha Rao, Karen O'Neill, Yoav Messinger, Dorothea E. Myers, Frederick Goldman, Carole Hurvitz, James T. Casper and Fatih M. Uckun

      Version of Record online: 8 MAR 2013 | DOI: 10.1177/00912709922012051

    2. Pharmacokinetic Changes of Theophylline and Amikacin through the Menstrual Cycle in Healthy Women (pages 1256–1262)

      Shunji Matsuki, Tsutomu Kotegawa, Kimiko Tsutsumi, Koichi Nakamura and Shigeyuki Nakano

      Version of Record online: 8 MAR 2013 | DOI: 10.1177/00912709922012060

    3. Pharmacokinetics and Pharmacodynamics following Intravenous Doses of Azimilide Dihydrochloride (pages 1263–1271)

      Alfred Corey, Jeffrey Agnew, Jose Brum, Nikhil Parekh, Suzanne Valentine and Melanie Williams

      Version of Record online: 8 MAR 2013 | DOI: 10.1177/00912709922012079

    4. Azimilide Pharmacokinetics following Intravenous and Oral Administration of a Solution and Capsule Formulation (pages 1272–1276)

      Mr. Alfred E. Corey, Jeffrey R. Agnew, Suzanne N. Valentine, John D. Nesbitt, Dan L. Wagner, James H. Powell and Gary A. Thompson

      Version of Record online: 8 MAR 2013 | DOI: 10.1177/00912709922012088

    5. A Pharmacokinetic Evaluation of Concomitant Administration of Linezolid and Aztreonam (pages 1277–1282)

      Theresa Lasher Sisson, Gail L. Jungbluth and Nancy K. Hopkins

      Version of Record online: 8 MAR 2013 | DOI: 10.1177/00912709922011962

  7. Drug Interactions

    1. Top of page
    2. Special Review
    3. Drug Metabolism
    4. Psychopharmacology
    5. Methods
    6. Pediatrics
    7. Pharmacokinetics and Pharmacodynamics
    8. Drug Interactions
    9. Adverse Effects
    10. Author Index, Volume 39 (1999)
    1. Lack of Pharmacokinetic Interaction between Lansoprazole and Intravenously Administered Phenytoin (pages 1283–1289)

      Michael D. Karol, Charles S. Locke and John H. Cavanaugh

      Version of Record online: 8 MAR 2013 | DOI: 10.1177/00912709922011971

  8. Adverse Effects

    1. Top of page
    2. Special Review
    3. Drug Metabolism
    4. Psychopharmacology
    5. Methods
    6. Pediatrics
    7. Pharmacokinetics and Pharmacodynamics
    8. Drug Interactions
    9. Adverse Effects
    10. Author Index, Volume 39 (1999)
    1. Severe Life-Threatening Hyponatremia during Paroxetine Therapy (pages 1290–1291)

      Majed Odeh, Hanna Seligmann and Arie Oliven

      Version of Record online: 8 MAR 2013 | DOI: 10.1177/00912709922011980

  9. Author Index, Volume 39 (1999)

    1. Top of page
    2. Special Review
    3. Drug Metabolism
    4. Psychopharmacology
    5. Methods
    6. Pediatrics
    7. Pharmacokinetics and Pharmacodynamics
    8. Drug Interactions
    9. Adverse Effects
    10. Author Index, Volume 39 (1999)
    1. Author Index, Volume 39 (1999) (pages 1294–1296)

      Version of Record online: 8 MAR 2013 | DOI: 10.1177/00912709922011999

SEARCH

SEARCH BY CITATION